Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark

This article was originally published in The Tan Sheet

Executive Summary

Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company

You may also be interested in...



Antiperspirant Duration Claim Restrictions Contested By CTFA

Restricting enhanced duration claims under the OTC Antiperspirant Drug Products Final Monograph violates First Amendment principles and is inconsistent with FDA regulatory precedent, according to the Cosmetic, Toiletry & Fragrance Association

FDA Antiperspirant Monograph Partial Stay Permits Enhanced Duration

OTC antiperspirant products claiming enhanced duration up to 48 hours will be permitted while FDA reviews new data, the agency says in an Oct. 15 Federal Register notice

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel